Mucosal Vaccination for Influenza Protection Enhanced by Catalytic Immune‐Adjuvant

Mucosal Vaccination for Influenza Protection Enhanced by Catalytic Immune‐Adjuvant

Abstract Influenza poses a severe threat to global health. Despite the whole inactivated virus (WIV)‐based nasal vaccine being a promising strategy for influenza protection, the mucosal barrier is still a bottleneck of the nasal vaccine. Here, a catalytic mucosal adjuvant strategy for an influenza W...

Full description

Bibliographic Details
Main Authors: Tao Qin, Shang Ma, Xinyu Miao, Yan Tang, Dandan Huangfu, Jinyuan Wang, Jing Jiang, Nuo Xu, Yuncong Yin, Sujuan Chen, Xiufan Liu, Yinyan Yin, Daxin Peng, Lizeng Gao
Format: Article
Language:English
Published: Wiley 2020-09-01
Series:Advanced Science
Subjects:
adjuvant
influenza virus
mucosal vaccine
nanozyme
Online Access:https://doi.org/10.1002/advs.202000771

Internet

https://doi.org/10.1002/advs.202000771

Similar Items